admin

An Amazon worker delivers packages amid the coronavirus disease (COVID-19) outbreak in Denver, Colorado, April 22, 2020. Kevin Mohatt | Reuters Though the markets are off from their highs, analysts believe that several companies still have room to grow. Innovations in point-of-sale technology, acquisitions of buy now, pay later firms, and trend shifts to cloud-computing
0 Comments
svetikd | E+ | Getty Images Millions of American families with kids have received three monthly payments since July totaling $45 billion through the new enhanced child tax credit. There’s a limited amount of time for families with eligible children to sign up if they didn’t get the checks automatically, likely because they don’t traditionally
0 Comments
SpaceX CEO Elon Musk poses with the crew before launch on September 15, 2021. John Kraus / Inspiration4 SpaceX CEO Elon Musk helped achieve the St. Jude Children’s Research Hospital fundraising goal of the Inspiration4 spaceflight, just hours after his company returned the crew from orbit. The main goal of the Inspiration4 mission, which launched
0 Comments
LifestyleVisuals | E+ | Getty Images Many older Americans worry about rising medical expenses, and those who may benefit most from a tax-friendly health savings account are the least likely to have one.  That’s according to a report from the National Poll on Healthy Aging, which surveyed Americans ages 50 to 80 about health expenses and savings. 
0 Comments
Investing in sustainable buildings could offer a real solution to reducing emissions in one of the world’s most polluting sectors, said Taronga Ventures, an investment firm focused on sustainable innovation and tech. Buildings currently represent 39% of global greenhouse emissions, according to U.N. data. Almost one-third (28%) of the global total is the result of
0 Comments
A nurse reaches for a vial of Pfizer-BioNTech Covid-19 vaccine at a pop up vaccine clinic in the Arleta neighborhood of Los Angeles, California, August 23, 2021. Robyn Beck | AFP | Getty Images An influential Food and Drug Administration advisory committee on Friday rejected a plan to administer booster shots of Pfizer and BioNTech’s
0 Comments